Comparing the effectiveness of competing tests for reducing colorectal cancer mortality

A network meta-analysis

B. Joseph Elmunzer, Amit G. Singal, Jeremy B. Sussman, Amar R Deshpande, Daniel A Sussman, Marisa L. Conte, Ben A. Dwamena, Mary A M Rogers, Philip S. Schoenfeld, John M. Inadomi, Sameer D. Saini, Akbar K. Waljee

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Comparative effectiveness data pertaining to competing colorectal cancer (CRC) screening tests do not exist but are necessary to guide clinical decision making and policy. Objective: To perform a comparative synthesis of clinical outcomes studies evaluating the effects of competing tests on CRC-related mortality. Design: Traditional and network meta-analyses. Two reviewers identified studies evaluating the effect of guaiac-based fecal occult blood testing (gFOBT), flexible sigmoidoscopy (FS), or colonoscopy on CRC-related mortality. Interventions: gFOBT, FS, colonoscopy. Main Outcome Measurements: Traditional meta-analysis was performed to produce pooled estimates of the effect of each modality on CRC mortality. Bayesian network meta-analysis (NMA) was performed to indirectly compare the effectiveness of screening modalities. Multiple sensitivity analyses were performed. Results: Traditional meta-analysis revealed that, compared with no intervention, colonoscopy reduced CRC-related mortality by 57% (relative risk [RR] 0.43; 95% confidence interval [CI], 0.33-0.58), whereas FS reduced CRC-related mortality by 40% (RR 0.60; 95% CI, 0.45-0.78), and gFOBT reduced CRC-related mortality by 18% (RR 0.82; 95% CI, 0.76-0.88). NMA demonstrated nonsignificant trends favoring colonoscopy over FS (RR 0.71; 95% CI, 0.45-1.11) and FS over gFOBT (RR 0.74; 95% CI, 0.51-1.09) for reducing CRC-related deaths. NMAbased simulations, however, revealed that colonoscopy has a 94% probability of being the most effective test for reducing CRC mortality and a 99% probability of being most effective when the analysis is restricted to screening studies. Limitations: Randomized trials and observational studies were combined within the same analysis. Conclusion: Clinical outcomes studies demonstrate that gFOBT, FS, and colonoscopy are all effective in reducing CRC-related mortality. Network meta-analysis suggests that colonoscopy is the most effective test.

Original languageEnglish
Pages (from-to)700-709
Number of pages10
JournalGastrointestinal Endoscopy
Volume81
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Colorectal Neoplasms
Sigmoidoscopy
Guaiac
Colonoscopy
Occult Blood
Mortality
Confidence Intervals
Meta-Analysis
Outcome Assessment (Health Care)
Network Meta-Analysis
Early Detection of Cancer
Observational Studies

ASJC Scopus subject areas

  • Gastroenterology
  • Radiology Nuclear Medicine and imaging

Cite this

Comparing the effectiveness of competing tests for reducing colorectal cancer mortality : A network meta-analysis. / Elmunzer, B. Joseph; Singal, Amit G.; Sussman, Jeremy B.; Deshpande, Amar R; Sussman, Daniel A; Conte, Marisa L.; Dwamena, Ben A.; Rogers, Mary A M; Schoenfeld, Philip S.; Inadomi, John M.; Saini, Sameer D.; Waljee, Akbar K.

In: Gastrointestinal Endoscopy, Vol. 81, No. 3, 01.03.2015, p. 700-709.

Research output: Contribution to journalArticle

Elmunzer, BJ, Singal, AG, Sussman, JB, Deshpande, AR, Sussman, DA, Conte, ML, Dwamena, BA, Rogers, MAM, Schoenfeld, PS, Inadomi, JM, Saini, SD & Waljee, AK 2015, 'Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: A network meta-analysis', Gastrointestinal Endoscopy, vol. 81, no. 3, pp. 700-709. https://doi.org/10.1016/j.gie.2014.10.033
Elmunzer, B. Joseph ; Singal, Amit G. ; Sussman, Jeremy B. ; Deshpande, Amar R ; Sussman, Daniel A ; Conte, Marisa L. ; Dwamena, Ben A. ; Rogers, Mary A M ; Schoenfeld, Philip S. ; Inadomi, John M. ; Saini, Sameer D. ; Waljee, Akbar K. / Comparing the effectiveness of competing tests for reducing colorectal cancer mortality : A network meta-analysis. In: Gastrointestinal Endoscopy. 2015 ; Vol. 81, No. 3. pp. 700-709.
@article{3c2dbfb2c7a74731a5e9e7bb621629d2,
title = "Comparing the effectiveness of competing tests for reducing colorectal cancer mortality: A network meta-analysis",
abstract = "Background: Comparative effectiveness data pertaining to competing colorectal cancer (CRC) screening tests do not exist but are necessary to guide clinical decision making and policy. Objective: To perform a comparative synthesis of clinical outcomes studies evaluating the effects of competing tests on CRC-related mortality. Design: Traditional and network meta-analyses. Two reviewers identified studies evaluating the effect of guaiac-based fecal occult blood testing (gFOBT), flexible sigmoidoscopy (FS), or colonoscopy on CRC-related mortality. Interventions: gFOBT, FS, colonoscopy. Main Outcome Measurements: Traditional meta-analysis was performed to produce pooled estimates of the effect of each modality on CRC mortality. Bayesian network meta-analysis (NMA) was performed to indirectly compare the effectiveness of screening modalities. Multiple sensitivity analyses were performed. Results: Traditional meta-analysis revealed that, compared with no intervention, colonoscopy reduced CRC-related mortality by 57{\%} (relative risk [RR] 0.43; 95{\%} confidence interval [CI], 0.33-0.58), whereas FS reduced CRC-related mortality by 40{\%} (RR 0.60; 95{\%} CI, 0.45-0.78), and gFOBT reduced CRC-related mortality by 18{\%} (RR 0.82; 95{\%} CI, 0.76-0.88). NMA demonstrated nonsignificant trends favoring colonoscopy over FS (RR 0.71; 95{\%} CI, 0.45-1.11) and FS over gFOBT (RR 0.74; 95{\%} CI, 0.51-1.09) for reducing CRC-related deaths. NMAbased simulations, however, revealed that colonoscopy has a 94{\%} probability of being the most effective test for reducing CRC mortality and a 99{\%} probability of being most effective when the analysis is restricted to screening studies. Limitations: Randomized trials and observational studies were combined within the same analysis. Conclusion: Clinical outcomes studies demonstrate that gFOBT, FS, and colonoscopy are all effective in reducing CRC-related mortality. Network meta-analysis suggests that colonoscopy is the most effective test.",
author = "Elmunzer, {B. Joseph} and Singal, {Amit G.} and Sussman, {Jeremy B.} and Deshpande, {Amar R} and Sussman, {Daniel A} and Conte, {Marisa L.} and Dwamena, {Ben A.} and Rogers, {Mary A M} and Schoenfeld, {Philip S.} and Inadomi, {John M.} and Saini, {Sameer D.} and Waljee, {Akbar K.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1016/j.gie.2014.10.033",
language = "English",
volume = "81",
pages = "700--709",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Comparing the effectiveness of competing tests for reducing colorectal cancer mortality

T2 - A network meta-analysis

AU - Elmunzer, B. Joseph

AU - Singal, Amit G.

AU - Sussman, Jeremy B.

AU - Deshpande, Amar R

AU - Sussman, Daniel A

AU - Conte, Marisa L.

AU - Dwamena, Ben A.

AU - Rogers, Mary A M

AU - Schoenfeld, Philip S.

AU - Inadomi, John M.

AU - Saini, Sameer D.

AU - Waljee, Akbar K.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Background: Comparative effectiveness data pertaining to competing colorectal cancer (CRC) screening tests do not exist but are necessary to guide clinical decision making and policy. Objective: To perform a comparative synthesis of clinical outcomes studies evaluating the effects of competing tests on CRC-related mortality. Design: Traditional and network meta-analyses. Two reviewers identified studies evaluating the effect of guaiac-based fecal occult blood testing (gFOBT), flexible sigmoidoscopy (FS), or colonoscopy on CRC-related mortality. Interventions: gFOBT, FS, colonoscopy. Main Outcome Measurements: Traditional meta-analysis was performed to produce pooled estimates of the effect of each modality on CRC mortality. Bayesian network meta-analysis (NMA) was performed to indirectly compare the effectiveness of screening modalities. Multiple sensitivity analyses were performed. Results: Traditional meta-analysis revealed that, compared with no intervention, colonoscopy reduced CRC-related mortality by 57% (relative risk [RR] 0.43; 95% confidence interval [CI], 0.33-0.58), whereas FS reduced CRC-related mortality by 40% (RR 0.60; 95% CI, 0.45-0.78), and gFOBT reduced CRC-related mortality by 18% (RR 0.82; 95% CI, 0.76-0.88). NMA demonstrated nonsignificant trends favoring colonoscopy over FS (RR 0.71; 95% CI, 0.45-1.11) and FS over gFOBT (RR 0.74; 95% CI, 0.51-1.09) for reducing CRC-related deaths. NMAbased simulations, however, revealed that colonoscopy has a 94% probability of being the most effective test for reducing CRC mortality and a 99% probability of being most effective when the analysis is restricted to screening studies. Limitations: Randomized trials and observational studies were combined within the same analysis. Conclusion: Clinical outcomes studies demonstrate that gFOBT, FS, and colonoscopy are all effective in reducing CRC-related mortality. Network meta-analysis suggests that colonoscopy is the most effective test.

AB - Background: Comparative effectiveness data pertaining to competing colorectal cancer (CRC) screening tests do not exist but are necessary to guide clinical decision making and policy. Objective: To perform a comparative synthesis of clinical outcomes studies evaluating the effects of competing tests on CRC-related mortality. Design: Traditional and network meta-analyses. Two reviewers identified studies evaluating the effect of guaiac-based fecal occult blood testing (gFOBT), flexible sigmoidoscopy (FS), or colonoscopy on CRC-related mortality. Interventions: gFOBT, FS, colonoscopy. Main Outcome Measurements: Traditional meta-analysis was performed to produce pooled estimates of the effect of each modality on CRC mortality. Bayesian network meta-analysis (NMA) was performed to indirectly compare the effectiveness of screening modalities. Multiple sensitivity analyses were performed. Results: Traditional meta-analysis revealed that, compared with no intervention, colonoscopy reduced CRC-related mortality by 57% (relative risk [RR] 0.43; 95% confidence interval [CI], 0.33-0.58), whereas FS reduced CRC-related mortality by 40% (RR 0.60; 95% CI, 0.45-0.78), and gFOBT reduced CRC-related mortality by 18% (RR 0.82; 95% CI, 0.76-0.88). NMA demonstrated nonsignificant trends favoring colonoscopy over FS (RR 0.71; 95% CI, 0.45-1.11) and FS over gFOBT (RR 0.74; 95% CI, 0.51-1.09) for reducing CRC-related deaths. NMAbased simulations, however, revealed that colonoscopy has a 94% probability of being the most effective test for reducing CRC mortality and a 99% probability of being most effective when the analysis is restricted to screening studies. Limitations: Randomized trials and observational studies were combined within the same analysis. Conclusion: Clinical outcomes studies demonstrate that gFOBT, FS, and colonoscopy are all effective in reducing CRC-related mortality. Network meta-analysis suggests that colonoscopy is the most effective test.

UR - http://www.scopus.com/inward/record.url?scp=84923285842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923285842&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2014.10.033

DO - 10.1016/j.gie.2014.10.033

M3 - Article

VL - 81

SP - 700

EP - 709

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 3

ER -